Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
1.58
Mar. 31, 2025 16:00:01- Change -0.12 (-7.05882%)
- Volume 226,480
- Today's Open 1.68
- Previous Close 1.7
- Today's High 1.7
- Today's Low 1.58
- 52 Week High 4.3
- 52 Week Low 1.57